DDX41 and glomerulonephritis: Consistent to this finding, the treatment by 14 M upon the immunization with WT-BMDC-ALD-DNA increased anti-DNA Abs production (Fig. 4c) as well as aggravated glomerulonephritis, increased autoantibody deposition and complement deposition (Fig. 4d–f).